HAEMOPHILIA AND BLOOD PRODUCTS
Parliamentary excerpt
That this House notes the recent report highlighting that the United Kingdom has the lowest provision of recombinant product for the use of people with haemophilia in the developed world; notes the recent medical concerns suggesting vCJD might be carried in infected blood products, and calls on the Government to make this synthetic alternative to blood products available to all people with haemophilia without further delay and thereby remove from patients with haemophilia the fear that the bl...